SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors react to a clinical trial update confirming 78 events in the pivotal REGAL study, bringing the company closer to the 80-event trigger for data unblinding. Community sentiment is highly polarized, with intense debate over the timing of final results, the company's strong cash position, and widespread speculation regarding potential buyout interest from big pharma.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies (MRAM) is currently experiencing significant market momentum driven by heavy retail investor interest, aggressive short-squeeze dynamics, and its strategic positioning as a critical component in Edge AI and data center memory solutions. The community is buzzing with enthusiasm regarding the stock's potential for sustained parabolic growth, comparing its trajectory to past major memory sector performers while actively debating the sustainability of current price action versus its long-term technological value.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as investors weigh its recent regulatory win, involving the approval of its reactor design criteria, against concerns regarding its pre-revenue status and significant insider share sales. While the community is actively debating the company's long-term potential as a critical energy provider for AI data centers, sentiment remains divided between those betting on government-backed expansion and those skeptical of the current valuation.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending as investors aggressively scrutinize the company's ability to translate defense partnerships and production capacity into tangible revenue ahead of its upcoming earnings report. The community is debating management's transparency and communication style while closely monitoring the stock's high short interest and potential catalysts from government drone procurement initiatives.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is seeing intensified market speculation driven by community discussions around potential data center storage partnerships and its role in defense-related battery applications. While investors remain eager for concrete news on production scale, the active trading sentiment is fueled by institutional positioning and high option volume, with many focusing on the company's long-term potential as an energy storage leader.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as investors digest reports that Nelson Peltz's Trian Fund Management is seeking financing for a potential take-private bid, sparking intense speculation about a short squeeze. Community discussion is focused on the stock's valuation gap relative to its peers and the high level of short interest, with many retail participants pushing for a significantly higher buyout price.

Rackspace Technology, Inc. engages in the provision of end-to-end multi-cloud technology services. The firm designs, builds and operates its customers’ cloud environments across technology platforms. It operates through the following segments: Multicloud Services and Apps & Cross Platform. The Multicloud Services segment includes public and private cloud managed services offerings, as well as professional services related to designing and building multicloud solutions and cloud-native applications. The Apps & Cross Platform segment includes managed applications, managed security and data services, as well as professional services related to designing and implementing application, security and data services. The company was founded on July 21, 2016 and is headquartered in San Antonio, TX.

Rackspace Technology Inc

Rackspace Technology is seeing significant momentum as investors digest a new memorandum of understanding with AMD for governed enterprise AI infrastructure alongside positive quarterly results. The community is actively debating the stock's potential for a broader re-rating while weighing risks related to the company's existing debt levels and the possibility of future equity offerings.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors debate whether the current price represents a deep-value opportunity or a value trap, with the community closely tracking its pivot into agentic AI orchestration and enterprise integration partnerships. While some participants express frustration over persistent share price weakness and perceived manipulation, others are aggressively accumulating shares, pointing to the company's strong cash position, lack of debt, and potential for long-term growth as the market rotates toward quality AI software.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending following a significant legal move to rescind its distribution agreement with Nippon Shinyaku, with investors viewing the challenge as a strategic step to regain control over commercialization ahead of an anticipated product approval. The community is actively discussing the potential for a more lucrative partnership or independent launch, fueling optimism that the company is clearing obstacles to capture the full value of its DMD therapy.

WORK Medical Technology Group Ltd. engages in the development of health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

Work Medical Technology Group Ltd - Ordinary Shares - Class A

Work Medical Technology Group Ltd

Work Medical Technology Group Ltd (WOK) continues to experience extreme volatility and intense retail attention following rapid price swings that have drawn comparisons to high-momentum Chinese stock runners. The community remains divided between day traders seeking aggressive squeeze opportunities and skeptics citing concerns over the company's financial fundamentals and historical pattern of dilutive offerings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CapsoVision (NASDAQ:CV) Stock Price Down 5.7%  - What's Next?

CapsoVision (NASDAQ:CV) Trading Down 5.7% - Here's What Happened...

CapsoVision, Inc. (NASDAQ:CV) Sees Significant Increase in Short Interest

CapsoVision, Inc. (NASDAQ:CV - Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 31st, there was short interest totaling 1,244,098 shares, an increase of 124.8% from the March 15th total of 553,348 shares. Approximately 2.5% of the...

Short Interest in CapsoVision, Inc. (NASDAQ:CV) Grows By 35.2%

CapsoVision, Inc. (NASDAQ:CV - Get Free Report) was the recipient of a large increase in short interest in the month of March. As of March 13th, there was short interest totaling 553,348 shares, an...

CapsoVision (NASDAQ:CV) Price Target Lowered to $10.00 at Benchmark

Benchmark lowered their target price on shares of CapsoVision from $14.00 to $10.00 and set a "speculative buy" rating on the stock in a research note on Friday...

CapsoVision Q4 Earnings Call Highlights

CapsoVision (NASDAQ:CV) executives highlighted continued commercial growth for its CapsoCam Plus small-bowel capsule endoscopy product and provided updates on regulatory and clinical milestones for...

CapsoVision Q4 25 Earnings Conference Call At 4:30 PM ET

(RTTNews) - CapsoVision, Inc (CV) will host a conference call at 4:30 PM ET on March 26, 2026, to discuss Q4 25 earnings results...

CapsoVision Conference: CEO Maps AI-Driven Capsule Endoscopy Roadmap for Colon and Pancreas Screening

CapsoVision (NASDAQ:CV) executives used a fireside chat hosted by Roth Senior Research Analyst Kyle Bauser to outline the company's origins, its capsule endoscopy platform for small bowel visualization, and development plans for future GI indications including colon and pancreas. Management also dis...

CapsoVision, Inc. (NASDAQ:CV) Short Interest Update

CapsoVision, Inc. (NASDAQ:CV - Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 13th, there was short interest totaling 429,030...

Short Interest in CapsoVision, Inc. (NASDAQ:CV) Increases By 281.0%

CapsoVision, Inc. (NASDAQ:CV - Get Free Report) saw a significant growth in short interest in January. As of January 30th, there was short interest totaling 357,735 shares, a growth of 281.0% from...

Short Interest in CapsoVision, Inc. (NASDAQ:CV) Declines By 57.4%

CapsoVision, Inc. (NASDAQ:CV - Get Free Report) was the target of a large decline in short interest during the month of January. As of January 15th, there was short interest totaling 93,892 shares, a...

CapsoVision, Inc. operates as a commercial-stage medical technology company. It engages in the development of imaging and artificial intelligence (AI) technologies that are deployed for endoscopy solutions to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. The firm developed capsule endoscope system, currently comprising the CapsoCam Plus single-use capsule and the CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to investigate abnormalities such as obscure GI bleeding and Crohn’s disease. The company was founded by Kang-Huai Wang on August 1, 2005 and is headquartered in Saratoga, CA.

CV
Central Vermont Public Service Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest CV News

CVCentral Vermont Public Service Corp.